Wir freuen uns darauf, am 5. und 6. Mai wieder am Swiss Biotech Day teilzunehmen. Als Pharma Consulting Firma mit Schweizer Standort in Basel sind wir stolz darauf, Mitglied der renommierten Swiss Biotech Association zu sein.
Unser diesjähriges Programm umfasst den Besuch ausgewählter Veranstaltungen und Panel-Diskussionen:
4. Mai, 17:30 – 20:30 | Welcome Reception
5. Mai, 10:00 – 11:00 | Swiss Biotech Association General Assembly
5. Mai, 15:30 – 16:15 | How to reach more patients faster: the promise of international collaboration and shared regulatory approval pathways
| Name | Position | Institution |
|---|---|---|
| Eveline Trachsel | Head of Medicinal Product Authorisation and Vigilance | Swissmedic, Swiss Agency for Therapeutic Products |
| Name | Position | Institution |
|---|---|---|
| Corinne Wenger | Head of Regulatory Affairs | Roche Pharma (Schweiz) AG |
| Sabine Ledderhose | Head of Regulatory Affairs | Astra Zeneca |
| Sergio Cantoreggi | Chief Scientific Officer | Sintetica S.A. |
5. Mai, 17:30 – 18:15 | Enhancing Europe’s Role as a Global Hub for Oncology Trials
| Name | Position | Institution |
|---|---|---|
| Rute Marques | CEO | ROK Communications |
| Name | Position | Institution |
|---|---|---|
| Pilar de la Rocha Mur | Head of Clinical Operations, EMEA | BeiGene |
| Dr. Anna Maria Frustaci | ASST Grande Ospedale Metropolitano Niguarda, Niguarda Cancer Center, Milan, Italy | |
| David Alsadius | Solid Tumor Franchise Lead | IQVIA |
6. Mai, 15:00 – 15:45 | Radioligand Therapies – Opportunities and Challenges for Switzerland and Globally
| Name | Position | Institution |
|---|---|---|
| Philippe Legenne | CMO | Molecular Partners |
| Name | Position | Institution |
|---|---|---|
| Melpomeni Fani | Head of Radiopharmaceutical Chemistry | University Hospital Basel |
| Sibylle Jennings | Global Regulatory Team Lead – Radiosensitive Cancers | Novartis |
| Emanuele Ostuni | CEO | ARTBIO |
| Arnaud Lesegretain | CEO | Orano Med |
6. Mai, 16:00 – 16:45 | From Innovation to Patient: Swissmedic’s Role in Accelerating Drug Development and Patient Access
| Name | Position | Institution |
|---|---|---|
| Eliane Schmid | Head of Communication | Swissmedic, Swiss Agency for Therapeutic Products |
| Name | Position | Institution |
|---|---|---|
| Benoît Dubuis | President | Fondation INARTIS |
| Laura Andrea Wyss | Associate Director Regulatory Strategy | Moderna Switzerland |
| Sandra Zaugg | Head Division Regulatory Assessment | Swissmedic |
| Julia Djonova | Head of Division Advanced Therapy Medicinal Products | Swissmedic |
| Deana Mohr | Project Leader | MUVON Therapeutics, ETH Zürich |
Wir freuen uns auf den Austausch mit internationalen Experten aus der Biotechnologiebranche.
